In summary, the majority of in vitro studies in macrophage models correlate very well with the data obtained in a wide range of animal models, demonstrating the anti-inflammatory effects of SGLT2 inhibitors in diabetes and other diseases. The gene discussed is SLC5A2; the disease is diabetes mellitus.